CAMK2G and myocardial infarction: Existing studies have confirmed that an increase of ROS production leading to CaMK II hyperactivity and perturbation in Ca2+ handing, and it has been reported to regulate and control inflammation-related diseases, such as reperfusion injury, myocardial infarction, and oligodendrocyte death [34–36].